# Neurons with granulovacuolar degeneration bodies are resilient to tau-induced protein synthesis impairment

**Authors:** Jasper F. M. Smits, Thijmen W. Ligthart, Marta Jorge-Oliva, Skip Middelhoff, Fleur Schipper, Débora Pita-Illobre, Ka Wan Li, Wiep Scheper

PMC · DOI: 10.1126/sciadv.aea8940 · 2026-03-06

## TL;DR

Some neurons in Alzheimer's disease resist damage from tau proteins by forming structures called GVBs, which help maintain protein production and protect against neurodegeneration.

## Contribution

The study identifies CK1δ as a key regulator of GVB formation, linking it to a protective stress response in neurons affected by tau pathology.

## Key findings

- GVB+ neurons are resilient to tau-induced impairment of global protein synthesis.
- GVB+ neurons retain the ability to induce long-term potentiation–induced protein synthesis despite tau pathology.
- CK1δ activity is essential for GVB formation and is sequestered in GVBs via autophagy.

## Abstract

In Alzheimer’s disease, many surviving neurons with tau pathology contain granulovacuolar degeneration bodies (GVBs), neuron-specific lysosomal structures induced by pathological tau assemblies. This could indicate a neuroprotective role for GVBs; however, the mechanism of GVB formation and its functional implications are elusive. Here, we demonstrate that casein kinase 1δ (CK1δ) activity is required for GVB formation. CK1δ is sequestered in the GVB during this process in an autophagy-dependent manner. We show that neurons with GVBs (GVB+) are resilient to tau-induced impairment of global protein synthesis and are protected against tau-mediated neurodegeneration. GVB+ neurons do not exhibit differential activation of transient translational stress responses but have increased ribosomal content. Unlike neurons without GVBs, GVB+ neurons fully retain the capacity to induce long-term potentiation–induced protein synthesis in the presence of tau pathology. Our results have identified CK1δ as a key regulator of GVB formation that confers a protective neuron-specific stress response to tau pathology. These findings provide opportunities for targeting neuronal resilience in tauopathies.

GVB+ neurons resist tau toxicity and maintain protein synthesis rates, revealing a protective, neuron-specific response.

## Linked entities

- **Proteins:** MAPT (microtubule associated protein tau)
- **Diseases:** Alzheimer’s disease (MONDO:0004975)

## Full-text entities

- **Genes:** Eif4ebp1 (eukaryotic translation initiation factor 4E binding protein 1) [NCBI Gene 13685] {aka 4e-bp1, PHAS-I}, Olig1 (oligodendrocyte transcription factor 1) [NCBI Gene 50914] {aka Bhlhb6, Olg-1, Oligo1, bHLHe21}, Ang (angiogenin, ribonuclease, RNase A family, 5) [NCBI Gene 11727] {aka Ang1, Rnase5, Rnase5a}, Rb1cc1 (RB1-inducible coiled-coil 1) [NCBI Gene 12421] {aka 2900055E04Rik, 5930404L04Rik, Cc1, FIP200, LaXp180}, Gfap (glial fibrillary acidic protein) [NCBI Gene 14580], SYNM (synemin) [NCBI Gene 23336] {aka DMN, SYN}, NUP62 (nucleoporin 62) [NCBI Gene 23636] {aka IBSN, SNDI, p62}, PDIK1L (PDLIM1 interacting kinase 1 like) [NCBI Gene 149420] {aka CLIK1L, STK35L2}, Lamp1 (lysosomal-associated membrane protein 1) [NCBI Gene 16783] {aka CD107a, LGP-120, LGP-A, Lamp-1, P2B, Perk}, RPL15 (ribosomal protein L15) [NCBI Gene 6138] {aka DBA12, EC45, L15, RPL10, RPLY10, RPYL10}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, Map2 (microtubule-associated protein 2) [NCBI Gene 17756] {aka G1-397-34, MAP-2, Mtap-2, Mtap2, repro4}, Omg (oligodendrocyte myelin glycoprotein) [NCBI Gene 18377], MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, Nes (nestin) [NCBI Gene 18008] {aka ESTM46, Ifaprc2, Marc2, RC2}, ARC (activity regulated cytoskeleton associated protein) [NCBI Gene 23237] {aka Arg3.1, hArc}, Aqp4 (aquaporin 4) [NCBI Gene 11829] {aka WCH4}, BYSL (bystin like) [NCBI Gene 705] {aka BYSTIN, Enp1}, LTV1 (LTV1 ribosome biogenesis factor) [NCBI Gene 84946] {aka C6orf93, IPHAK, dJ468K18.4}, SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, ANG (angiogenin) [NCBI Gene 283] {aka ALS9, HEL168, RAA1, RNASE4, RNASE5}, CSNK1D (casein kinase 1 delta) [NCBI Gene 1453] {aka ASPS, CKI-delta, CKId, CKIdelta, FASPS2, HCKID}, RPL24 (ribosomal protein L24) [NCBI Gene 6152] {aka HEL-S-310, L24, eL24}, Atg5 (autophagy related 5) [NCBI Gene 11793] {aka 2010107M05Rik, 3110067M24Rik, Apg5l, Atg5l, Paddy}, FOS (Fos proto-oncogene, AP-1 transcription factor subunit) [NCBI Gene 2353] {aka AP-1, C-FOS, p55}, RPS12 (ribosomal protein S12) [NCBI Gene 6206] {aka S12, eS12}
- **Diseases:** Pick's disease (MESH:D020774), FTD (MESH:D057180), progressive supranuclear palsy (MESH:D013494), neuronal (MESH:D009410), tauopathies (MESH:D024801), toxicity (MESH:D064420), amyotrophic lateral sclerosis (MESH:D000690), Granulovacuolar degeneration (MESH:C564974), AD (MESH:D000544), Down syndrome (MESH:D004314), neurodegeneration (MESH:D019636)
- **Chemicals:** TBS-T (MESH:C027647), Tween (MESH:D011136), bicuculline (MESH:D001640), Sar405 (MESH:C000594652), Coomassie Blue (MESH:C048139), poly-l-ornithine (MESH:C008973), PepA (MESH:C031375), formaldehyde (MESH:D005557), ammoniumpersulfate (MESH:C031276), 4',6-diamidino-2-phenylindole (MESH:C007293), dimethyl sulfoxide (MESH:D004121), FA (MESH:D005492), calcium (MESH:D002118), CO2 (MESH:D002245), DIA- (MESH:C076868), N,N,N',N'-tetramethylethylene-diamine (MESH:C005798), cysteine (MESH:D003545), ammonium sulfate (MESH:D000645), phosphoric acid (MESH:C030242), forskolin (MESH:D005576), amino acid (MESH:D000596), trifluoroacetic acid (MESH:D014269), oil (MESH:D009821), BafA1 (-), Puromycin (MESH:D011691), glycerol (MESH:D005990), penicillin (MESH:D010406), HEPES (MESH:D006531), NB (MESH:D009556), DTT (MESH:D004229), N-methyl-d-aspartate (MESH:D016202), Bafilomycin A1 (MESH:C040929), SDS (MESH:D012967), ethanol (MESH:D000431), acrylamide (MESH:D020106), Glutamax (MESH:C054122), PF-670462 (MESH:C522839), H2O (MESH:D014867), Anisomycin (MESH:D000841), TM (MESH:D014415), MG132 (MESH:C072553), N (MESH:D009584), bromophenol blue (MESH:D001978), acetonitrile (MESH:C032159), Coomassie brilliant blue G-250 (MESH:C004692), Triton X-100 (MESH:D017830), streptomycin (MESH:D013307), rapamycin (MESH:D020123), polyacrylamide (MESH:C016679), Dox (MESH:D004318), methanol (MESH:D000432), DAP (MESH:C041756), 4-aminopyridine (MESH:D015761), O (MESH:D010100)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Caenorhabditis elegans (species) [taxon 6239], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932]
- **Mutations:** K38M, P301L, E64D, G to I, G to K, E to G, A to D, C to F, A to C, AAG to ATG, serine/threonine, S320F
- **Cell lines:** FTDtau1 + 2 — Rattus norvegicus (Rat), Adenocarcinoma of the rat prostate, Cancer cell line (CVCL_3569), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), 2N4R — Homo sapiens (Human), Acute promyelocytic leukemia with PML-RARA, Cancer cell line (CVCL_U087), S2O — Mus musculus (Mouse), Hybridoma (CVCL_C0ZA), S2P — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12965320/full.md

---
Source: https://tomesphere.com/paper/PMC12965320